Skip to main content

Corbus Pharmaceuticals Holdings, Inc.

CRBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001595097

In the last 90 days, Corbus Pharmaceuticals Holdings, Inc. insiders filed 1 open-market purchase and 3 sales; 107 institutions reported holding it in 13F filings for Q2 2026, worth $129.1M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Corbus Pharmaceuticals Holdings, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of CRBP: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders9987−12
Shares49.6M44.8M−4.83M (−9.7%)
Value$91.0M$45.6M−$45.3M (−49.8%)

New holders (11)

Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to CRBP in Q3 2021
InstitutionSharesValue% of portfolio
Vident Investment Advisory, LLC147,113$150.0K0.00%
Jacobs Levy Equity Management, Inc114,466$117.0K0.00%
Two Sigma Investments, LP104,819$107.0K0.00%
XTX Topco Ltd41,599$42.0K0.01%
Wolverine Trading, LLC27,811$28.0K0.00%
Qube Research & Technologies Ltd12,464$13.0K0.00%
Baird Financial Group, Inc.11,000$11.0K0.00%
Newbridge Financial Services Group, Inc.11,000$11.0K0.01%
Federated Hermes, Inc.1,762$2.00K0.00%
Toronto Dominion Bank4$00.00%
IFP Advisors, Inc100––

Sold out (23)

Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.